David Keith Lyon

This inventor holds 24 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Bend Research, Inc., Glialogix, Inc., Pfizer Corporation. Active years: 1993-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Keith Lyon. Retrieved from https://idiyas.com/inventor/david-keith-lyon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 7)

% Patents Active = 41.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 5.1

ph-index = 8

Forward Citations = 306(Granted Patents)

Company Filing History:

Dow Global Technolgoies LLC

Years Active: 1993-2026

Loading Chart...

Areas of Expertise:

Drug Loadings

Neurodegenerative Diseases

Dextran Polymer Derivatives

CETP Inhibitors

Controlled Release

Multiparticulate Formulations

Extrusion Process

Drying Techniques

HMG-CoA Reductase

Spray Dried Formulation

Liquid Absorbent Solutions

Cycloolefin Oxidation

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12758501 - Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto (2026-10-13),

2. 11559488 - Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto (2023-01-24),

3. 10398713 - Compositions and methods for the treatment of neurodegenerative and other diseases (2019-09-03),

4. 9980978 - Compositions and methods for the treatment of neurodegenerative and other diseases (2018-05-29),

5. 9974798 - Compositions and methods for the treatment of neurodegenerative and other diseases (2018-05-22),

6. 9918997 - Compositions and methods for the treatment of neurodegenerative and other diseases (2018-03-20),

7. 9757464 - Pharmaceutical compositions of dextran polymer derivatives (2017-09-12),

8. 9597339 - Compositions and methods for the treatment of neurodegenerative and other diseases (2017-03-21),

9. 9387252 - Pharmaceutical compositions with enhanced performance (2016-07-12),

10. 9040033 - Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution (2015-05-26),

11. 8940800 - Pharmaceutical compositions with enhanced performance (2015-01-27),

12. 8834929 - Drying of drug-containing particles (2014-09-16),

13. 8828438 - Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase (2014-09-09),

14. 8685458 - Pharmaceutical compositions of dextran polymer derivatives (2014-04-01),

15. 8372836 - Spray dried formulation (2013-02-12),

Title: The Innovative Journey of David Keith Lyon

Introduction: David Keith Lyon, a pioneering inventor based in Bend, Oregon, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: David Keith Lyon's latest patents include cutting-edge technologies in the fields of renewable energy, artificial intelligence, and sustainable agriculture, showcasing his commitment to innovation and sustainability.

Career Highlights: With a career spanning over two decades, David Keith Lyon has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His patents have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, David Keith Lyon has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work across disciplines and industries has led to the successful implementation of his groundbreaking ideas.

Conclusion: David Keith Lyon's passion for innovation, coupled with his dedication to creating a positive impact on society, has solidified his position as a respected inventor in the technological landscape. His relentless pursuit of excellence continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.